These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7900235)

  • 1. Weekly vinorelbine in elderly patients with non-small-cell lung cancer.
    Colleoni M; Gaion F; Nelli P; Colmellere GM; Manente P
    Tumori; 1994 Dec; 80(6):448-52. PubMed ID: 7900235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.
    Vokes EE; Rosenberg RK; Jahanzeb M; Craig JB; Gralla RJ; Belani CP; Jones SE; Bigley JW; Hohneker JA
    J Clin Oncol; 1995 Mar; 13(3):637-44. PubMed ID: 7533824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.
    Clark JI; Kancharla K; Qamar R; Fisher S; Hantel A; Panganiban J; Millbrandt L; Albain KS
    Lung Cancer; 2001 Nov; 34(2):271-7. PubMed ID: 11679186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study.
    Gridelli C; Perrone F; Gallo C; De Marinis F; Ianniello G; Cigolari S; Cariello S; Di Costanzo F; D'Aprile M; Rossi A; Migliorino R; Bartolucci R; Bianco AR; Pergola M; Monfardini S
    Eur J Cancer; 1997 Mar; 33(3):392-7. PubMed ID: 9155522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage III-B non-small-cell lung cancer patients.
    Felip E; Del Campo JM; Bodi R; Vera R; Casado S; Rubio D
    Am J Clin Oncol; 1997 Aug; 20(4):404-6. PubMed ID: 9256899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study.
    Feliu J; Martin G; Lizón J; Chacón JI; Dorta J; de Castro J; Rodríguez A; Sánchez Heras B; Torrego JC; Espinosa E; González Barón M;
    Ann Oncol; 2001 Oct; 12(10):1369-74. PubMed ID: 11762806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).
    Kudoh S; Takeda K; Nakagawa K; Takada M; Katakami N; Matsui K; Shinkai T; Sawa T; Goto I; Semba H; Seto T; Ando M; Satoh T; Yoshimura N; Negoro S; Fukuoka M
    J Clin Oncol; 2006 Aug; 24(22):3657-63. PubMed ID: 16877734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer.
    Horvath L; Boyer M; Clarke S; Beale P; Beith J; Underhill C; Stockler M; Bishop J
    Lung Cancer; 2001 May; 32(2):173-8. PubMed ID: 11325488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UFT plus vinorelbine in advanced non-small cell lung cancer: a phase I and an elderly patient-directed phase II study.
    Igishi T; Shigeoka Y; Yasuda K; Suyama H; Katayama S; Sugitani A; Matsumoto S; Yamamoto M; Ueda Y; Takeda K; Sumikawa T; Sako T; Kodani M; Hitsuda Y; Shimizu E
    J Thorac Oncol; 2009 Mar; 4(3):376-82. PubMed ID: 19190514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin and vinorelbine in elderly patients with non-small cell lung cancer.
    Colleoni M; Vicario G; Nelli P; Sgarbossa G; Pancheri F; Manente P
    Oncol Rep; 1996 Nov; 3(6):1035-8. PubMed ID: 21594502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity.
    Kanard A; Jatoi A; Castillo R; Geyer S; Schulz TK; Fitch TR; Rowland KM; Nair S; Krook JE; Kugler JW
    Lung Cancer; 2004 Mar; 43(3):345-53. PubMed ID: 15165094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group.
    Furuse K; Kubota K; Kawahara M; Ogawara M; Kinuwaki E; Motomiya M; Nishiwaki Y; Niitani H; Sakuma A
    Lung Cancer; 1994 Dec; 11(5-6):385-91. PubMed ID: 7704495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.
    Hirose T; Mizutani Y; Ohmori T; Ishida H; Hosaka T; Ando K; Shirai T; Okuda K; Ohnishi T; Horichi N; Kubota H; Adachi M
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):361-7. PubMed ID: 16331494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy.
    Leu KM; Kim KM; Larson M; Larson M; Schiller JH
    Lung Cancer; 2001 Oct; 34(1):105-13. PubMed ID: 11557120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M; Provencio M; Utracka-Hutka B; Villa E; Codes M; Kuten A; Henke M; Lopez M; Bell D; Biti G; Merimsky O; Beorchia A; Riggi M; Caux NR; Pouget JC; Dubray B; David P
    J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
    Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance status.
    Camerini A; Valsuani C; Mazzoni F; Siclari O; Puccetti C; Donati S; Rondini M; Tartarelli G; Puccinelli P; Di Costanzo F; Amoroso D
    Ann Oncol; 2010 Jun; 21(6):1290-1295. PubMed ID: 19914959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC). The Japan Vinorelbine Lung Cancer Cooperative Study Group.
    Furuse K; Fukuoka M; Kuba M; Yamori S; Nakai Y; Negoro S; Katagami N; Takada Y; Kinuwaki E; Kawahara M; Kubota K; Sakuma A; Niitani H
    Ann Oncol; 1996 Oct; 7(8):815-20. PubMed ID: 8922195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients.
    Sorraritchingchai S; Thongprasert S; Charoentum C; Chewasakulyong B; Moonprakan S
    J Med Assoc Thai; 2004 Apr; 87(4):367-71. PubMed ID: 15217171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.